Agilent Technologies Return on Equity

Agilent Technologies (A) currently reports a ROE of 19.56%. That is above the Healthcare sector average of 13.26%. Use the charts on this page to explore Agilent Technologies's ROE history and peer comparisons.

Agilent Technologies's ROE of 19.56% is higher than the Healthcare sector average of 13.26%. That is roughly 47.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Agilent Technologies's current 19.56% should be judged against Healthcare norms (sector average: 13.26%) and against A's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 19.56%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.26%. From there, open related valuation or income-statement pages for Agilent Technologies, and consider following A for alerts when major investors trade the stock.

Agilent Technologies is classified in the Healthcare sector. On ROE, it currently shows 19.56% versus a sector average near 13.26%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing A with unrelated industries.